Antimicrobial Agents and Chemotherapy · 2012 · 145 citations · 17 references
MedicinePharmacokineticsPharmacologyAntimicrobial PharmacologyAntimicrobial ResistanceTuberculosis ControlAnthelmintic PharmacologyAnthelmintic ResistanceAntibacterial AgentsAntibacterial PharmacologyAntibiotic ResistanceTuberculosis PharmacotherapyAnthelmintic AgentsAnthelmintic TreatmentAnti-tuberculosis Drug RepurposingDrug-resistant PathogensExtensively Drug-resistant Tuberculosis TreatmentMultidrug-resistant OrganismsMycobacterial DiseaseTuberculosis Drug Resistance
Avermectins are a family of macrolides known for their anthelmintic activities and traditionally believed to be inactive against all bacteria. Here we report that members of the family, ivermectin, selamectin, and moxidectin, are bactericidal against mycobacterial species, including multidrug-resistant and extensively drug-resistant clinical strains of Mycobacterium tuberculosis. Avermectins are approved for clinical and veterinary uses and have documented pharmacokinetic and safety profiles. We suggest that avermectins could be repurposed for tuberculosis treatment.
17
Curtis R. Chong, David Sullivan · Nature · 2007 · 1K citations
Kévin Pethe, Patrícia Carvalho de Sequeira, Sanjay Agarwalla et al. · Nature Communications · 2010 · 308 citations · Full text